The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Open accessAbstract
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the brains of individuals with AD and preclinical AD (i.e., evidence of Aβ and tau deposition in the brain without any clinical manifestation of the disease), as well as patients with MCI (a mild clinical impairment with no proof of underlying pathology with biomarkers), many oxidative damage products are measured, and numerous investigations have pointed to OS as a key and early player in the”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the AD brain, mitochondria can be sources of ROS and also the target of OS, especially mitochondrial DNA (mtDNA) is susceptible to oxidative damage [19,53,63].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“Oxidative damage to RNA in EC, hippocampus, subiculum, and temporal neocortex of subjects with AD has been described. The levels of 8-OHdG increase early before pathological changes occur, and this can explain that the selective vulnerability of neurons in the EC during AD may be related to the vulnerability of these particular neurons to oxidative damage [19].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Research works printed but not linked: 2
- Smith, 1998, ApoE: Isoform specific antioxidant activity [abstract], Neurobiol Aging, 19, S222
- Nunomura, 2000, Increasing amyloid ß 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease [abstract], Brain pathol, 10, 783
Cited by
Sorted by citations
Items 801–900 of 1,005
Dorszewska, J., Kempisty, B., Jaroszewska-Kolecka, J., Różycka, A., Florczak, J., Lianeri, M., Jagodziński, P. P., & Kozubski, W. P. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0926 · Cited by 52
Protection against β-amyloid induced abnormal synaptic function and cell death by Ginkgolide J
Vitolo, O. V., Gong, B., Cao, Z., Ishii, H., Jaracz, S., Nakanishi, K., Arancio, O., Dzyuba, S. V., Lefort, R., & Shelanski, M. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.025 · Cited by 52
Hirata, K., Yamaguchi, H., Takamura, Y., Takagi, A., Fukushima, T., Iwakami, N., Saitoh, A., Nakagawa, M., & Yamada, T. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083543 · Cited by 52
Hayashi, M., Araki, S., Kohyama, J., Shioda, K., & Fukatsu, R. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.04.001 · Cited by 51
Oka, S., Leon, J., Sakumi, K., Abolhassani, N., Sheng, Z., Tsuchimoto, D., LaFerla, F. M., & Nakabeppu, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84640-9 · Cited by 51
Ghavanloo, E., Rafii‐Tabar, H., Kausar, A., Giannopoulos, G. I., & Fazelzadeh, S. A. (2022) · Physics Reports · doi:10.1016/j.physrep.2022.10.003 · Cited by 51
Hung, V. W. S., Masoom, H., & Kerman, K. (2012) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2012.05.023 · Cited by 51
Curcumin: a natural substance with potential efficacy in Alzheimer’s disease
Potter, P. E. (2013) · Journal of Experimental Pharmacology · doi:10.2147/jep.s26803 · Cited by 51
Aliev, G., Li, Y., Palacios, H. H., & Obrenovich, M. E. (2011) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489011797376942 · Cited by 51
Self-citationLang, M., Fan, Q., Wang, L., Zheng, Y., Xiao, G., Wang, X., Wang, W., Zhong, Y., & Zhou, B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.029 · Cited by 51
Yang, R., Wang, Q., Min, L., Sui, R., Li, J., & Liu, X. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1263-y · Cited by 51
Belkacemi, A., & Ramassamy, C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.020 · Cited by 51
Zhou, X., Yao, Z., Peng, Y., Mao, S., Xu, D. M., Qin, X., & Zhang, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-26962-9 · Cited by 51
Wu, G., Li, Z., Li, X., Zheng, T., & Zhang, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113128 · Cited by 51
Moreira, P. I., Honda, K., Zhu, X., Nunomura, A., Casadesús, G., Smith, M. A., & Perry, G. L. (2006) · Neurology · doi:10.1212/01.wnl.0000192307.15103.83 · Cited by 51
Self-citationReproductive Hormones Modulate Oxidative Stress in Alzheimer's Disease
Barron, A. M., Fuller, S. J., Verdile, G., & Martins, R. N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2047 · Cited by 51
Maynard, S., Hejl, A., Dinh, T.-S. T., Keijzers, G., Hansen, Å. M., Desler, C., Moreno‐Villanueva, M., Bürkle, A., Rasmussen, L. J., Waldemar, G., et al. (2015) · Aging · doi:10.18632/aging.100810 · Cited by 51
Whitmore, C. A., Haynes, J. R., Behof, W. J., Rosenberg, A. J., Tantawy, M. N., Hachey, B. C., Wadzinski, B. E., Spiller, B. W., Peterson, T. E., Paffenroth, K. C., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060742 · Cited by 50
Microglia-derived extracellular vesicles trigger age-related neurodegeneration upon DNA damage
Arvanitaki, E. S., Goulielmaki, E., Gkirtzimanaki, K., Niotis, G., Tsakani, E., Nenedaki, E., Rouska, I., Kefalogianni, M., Xydias, D., Kalafatakis, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317402121 · Cited by 50
Fukuhara, K., Ohno, A., Ota, Y., Senoo, Y., Maekawa, K., Okuda, H., Kurihara, M., Okuno, A., Niida, S., Saito, Y., et al. (2013) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-118 · Cited by 50
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 50
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 50
Mitochondrial DNA Sequence Variation Associated with Dementia and Cognitive Function in the Elderly
Tranah, G. J., The Health, A. A. B. C. S., Nalls, M. A., Katzman, S. M., Yokoyama, J. S., Lam, E. T., Zhao, Y., Mooney, S. D., Thomas, F., Newman, A. B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120466 · Cited by 50
Choi, H. J., Kang, K. S., Fukui, M., & Zhu, B. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01041.x · Cited by 50
Chronological primacy of oxidative stress in Alzheimer disease
Smith, M. A., Nunomura, A., Lee, H., Zhu, X., Moreira, P. I., Ávila, J., & Perry, G. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.021 · Cited by 50
Self-citationOyamada, R., Hayashi, M., Katoh, Y., Tsuchiya, K., Mizutani, T., Tominaga, I., & Kashima, H. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00662.x · Cited by 50
The Contribution of Luteinizing Hormone to Alzheimer Disease Pathogenesis
Webber, K. M., Perry, G. L., Smith, M. A., & Casadesús, G. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.741 · Cited by 50
Self-citationOxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 50
Dezor, M., Dorszewska, J., Florczak, J., Kempisty, B., Jaroszewska-Kolecka, J., Różycka, A., Półrolniczak, A., Bugaj, R., Jagodziński, P. P., & Kozubski, W. P. (2011) · PubMed · Cited by 49
Elmegeed, G. A., Ahmed, H. H., Hashash, M. A., Abdelhalim, M. M., & El-kady, D. S. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.003 · Cited by 49
Szaingurten‐Solodkin, I., Hadad, N., & Lévy, R. (2009) · Glia · doi:10.1002/glia.20886 · Cited by 49
Castellani, R. J., Gupta, Y., Sheng, B., Siedlak, S. L., Harris, P. L. R., Coller, J., Perry, G. L., Lee, H., Tabaton, M., Smith, M. A., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.149 · Cited by 49
Self-citationMoskovitz, J., Maiti, P., Lopes, D. H. J., Oien, D. B., Attar, A., Liu, T., Mittal, S., Hayes, J., & Bitan, G. (2011) · Biochemistry · doi:10.1021/bi201426b · Cited by 49
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Hofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 49
Self-citationEffect of walnut protein hydrolysate on scopolamine-induced learning and memory deficits in mice
Li, W., Zhao, T., Zhang, J., Xu, J., Sun‐Waterhouse, D., Zhao, M., & Su, G. (2017) · Journal of Food Science and Technology · doi:10.1007/s13197-017-2746-x · Cited by 49
Nunomura, A., Lee, H., Zhu, X., & Perry, G. L. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160433 · Cited by 49
Self-citationJan, A. T., Azam, M., Rahman, S., Almigeiti, A. M. S., Choi, D. H., Lee, E. J., Haq, Q. M. R., & Choi, I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00356 · Cited by 49
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51
Iron genes, iron load and risk of Alzheimer’s disease
Lehmann, D. J., Worwood, M., Ellis, R., Wimhurst, V. L. J., Merryweather‐Clarke, A. T., Warden, D. R., Smith, A. D., & Robson, K. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.040519 · Cited by 49
Amyloid β and neuromelanin—Toxic or protective molecules?The cellular context makes the difference
Rao, K. S. J., Hegde, M. L., Anitha, S., Musicco, M., Zucca, F. A., TURRO, N. J., & Zecca, L. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.004 · Cited by 49
Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme
Gibson, G. E., Zhang, H., Xu, H., Park, L. C. H., & Jeitner, T. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00091-6 · Cited by 49
Activation of mitogen‐activated protein kinases in hamster brains infected with 263K scrapie agent
Lee, H., Jun, Y.-C., Choi, J., Kim, J., Carp, R. I., & Kim, Y. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03429.x · Cited by 49
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease
Marlatt, M. W., Lee, H., Perry, G. L., Smith, M. A., & Zhu, X. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1493 · Cited by 49
Self-citationEpigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells
Guo, X., Wu, X., Ren, L.-N., Liu, G., & Li, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.012 · Cited by 48
The inverse association of cancer and Alzheimer's: a bioenergetic mechanism
Demetrius, L., & Simon, D. K. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0006 · Cited by 48
Du, F., Zhang, Z., Li, H., Yu, Q., Douglas, J. T., Bratasz, A., Kuppusamy, P., & Yan, S. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150917 · Cited by 48
Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 48
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
Islam, B. U., Jabir, N. R., & Tabrez, S. S. M. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1584808 · Cited by 48
AMPK: Potential Therapeutic Target for Alzheimer's Disease
Yang, L., Jiang, Y., Shi, L., Zhong, D., Li, Y., Li, J., & Jin, R. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190819142746 · Cited by 48
Shukla, M., & Vincent, B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101062 · Cited by 52
Soler‐López, M., Badiola, N., Zanzoni, A., & Aloy, P. (2012) · BioEssays · doi:10.1002/bies.201100193 · Cited by 48
Peuchant, E., Richard‐Harston, S., Bourdel‐Marchasson, I., Dartigues, J., Letenneur, L., Barberger‐Gateau, P., Dabernat, S., & Daniel, J. Y. (2008) · Translational research · doi:10.1016/j.trsl.2008.05.009 · Cited by 48
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
Plascencia‐Villa, G., & Perry, G. L. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.07.002 · Cited by 47
Self-citationEarly Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Yu, F., Gong, P., Hu, Z., Qiu, Y. L., Cui, Y., Gao, X., Chen, H., & Li, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0343-3 · Cited by 47
The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival
Lee, H., Zhu, X., Casadesús, G., Pallàs, M., Camins, A., O'Neill, M. J., Nakanishi, S., Perry, G. L., & Smith, M. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.055 · Cited by 47
Self-citationJones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47
Energy and the Alzheimer brain
Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 47
Kampen, J. M. V., & Kay, D. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182896 · Cited by 47
Li, H., Yang, P., Knight, W. C., Guo, Y., Perlmutter, J. S., Benzinger, T. L. S., Morris, J. C., & Xu, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14898 · Cited by 47
Rehman, I., Ahmad, R., Khan, I., Lee, H. J., Park, J., Ullah, R., Choi, M. J., Kang, H. Y., & Kim, M. O. (2021) · Biomedicines · doi:10.3390/biomedicines9040408 · Cited by 47
RetractedAntioxidants and Alzheimerʼs disease: from bench to bedside (and back again)
Rutten, B. P. F., Steinbusch, H. W. M., Korr, H., & Schmitz, C. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200211000-00006 · Cited by 47
Balogiannis, S., Costa, V., Mavroudis, I. A., Psaroulis, D., Manolides, S. L., & Manolides, L. S. (2007) · Acta Oto-Laryngologica · doi:10.1080/00016480601126986 · Cited by 47
Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1
He, W., Wang, Y., Liu, W., & Zhou, C. (2007) · BMC Structural Biology · doi:10.1186/1472-6807-7-38 · Cited by 47
Applications of the Keap1–Nrf2 system for gene and cell therapy
Kanninen, K. M., Pomeshchik, Y., Leinonen, H. M., Malm, T., Koıstınaho, J., & Levonen, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.037 · Cited by 47
Bianco, N. R., Perry, G. L., Smith, M. A., Templeton, D. J., & Montano, M. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0382 · Cited by 47
Self-citationAltered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease
Lillenes, M. S., Rabano, A., Støen, M., Riaz, T., Misaghian, D., Møllersen, L., Esbensen, Y., Günther, C.-C., Selnes, P., Stenset, V. T. V., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0237-z · Cited by 46
Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
Arbez‐Gindre, C., Steele, B. R., & Micha‐Screttas, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030898 · Cited by 46
Khalil, A., Berrougui, H., Pawelec, G., & Fülöp, T. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.11.008 · Cited by 46
Xu, Z., Zhang, L., Wang, Q., Marshall, C., Xiao, N., Gao, J., Wu, T., Ding, J., Hu, G., & Xiao, M. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12139 · Cited by 46
Minniti, A. N., Rebolledo, D. L., Grez, P. M., Fadić, R., Aldunate, R., Volitakis, I., Cherny, R. A., Opazo, C., Masters, C. L., Bush, A. I., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-2 · Cited by 46
Cai, H.-Y., Wang, Z., Hölscher, C., Li, Y., Zhang, J., Sun, P., Li, J., Yang, W., Wu, M., & Qi, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.033 · Cited by 46
Genistein, a tool for geroscience
Mas‐Bargues, C., Borrás, C., & Viña, J. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111665 · Cited by 46
Mitochondrial DNA variants in a Japanese population of patients with Alzheimer’s disease
Tanaka, N., Goto, Y., Akanuma, J., Kato, M., Kinoshita, T., Yamashita, F., Tanaka, M., & Asada, T. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.08.008 · Cited by 46
Understanding the link between cancer and neurodegeneration
Driver, J. A. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.007 · Cited by 46
Mitochondrial Swelling Impairs the Transport of Organelles in Cerebellar Granule Neurons
Kaasik, A., Safiulina, D., Choubey, V., Kuum, M., Zharkovsky, A., & Veksler, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702295200 · Cited by 46
Chandran, S., & Binninger, D. (2023) · Antioxidants · doi:10.3390/antiox13010021 · Cited by 45
Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
Santos, R. X., Correia, S. C., Cardoso, S., Carvalho, C., Santos, M. S., & Moreira, P. I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07262.x · Cited by 45
Sinha, M. S., Bhowmick, P., Banerjee, A., & Chakrabarti, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.036 · Cited by 45
Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses
Hachiya, Y., Hayashi, M., Kumada, S., Uchiyama, A., Tsuchiya, K., & Kurata, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0024-x · Cited by 45
Coppedè, F., Mancuso, M., Gerfo, A. L., Manca, M. L., Petrozzi, L., Migliore, L., Siciliano, G., & Murri, L. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.035 · Cited by 45
Chen, K., Possidente, B. P., Lomas, D. A., & Crowther, D. C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014134 · Cited by 45
Serviddio, G., Romano, A. D., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 45
Zhu, X., Castellani, R. J., Moreira, P. I., Aliev, G., Shenk, J. C., Siedlak, S. L., Harris, P. L. R., Fujioka, H., Sayre, L. M., Szweda, P. A., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.004 · Cited by 45
Self-citationCompensatory responses induced by oxidative stress in Alzheimer disease
Moreira, P. I., Zhu, X., Liu, Q., Honda, K., Siedlak, S. L., Harris, P. L. R., Smith, M. A., & Perry, G. L. (2006) · Biological Research · doi:10.4067/s0716-97602006000100002 · Cited by 45
Self-citationEvidence for nucleolar dysfunction in Alzheimer’s disease
Nyhus, C., Pihl, M., Hyttel, P., & Hall, V. J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0104 · Cited by 44
Uddin, M. S., Kabir, M. T., Rahman, M. M., Mathew, B., Shah, M. A., & Ashraf, G. M. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13244 · Cited by 44
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
Shang, D., Huang, M., Wang, B., Yan, X., Wu, Z., & Zhang, X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220810114644 · Cited by 44
Green, M. C., Fedorov, D. G., Kitaura, K., Francisco, J. S., & Slipchenko, L. V. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4790616 · Cited by 44
Mallei, A., Giambelli, R., Gass, P., Racagni, G., Mathé, A. A., Vollmayr, B., & Popoli, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.012 · Cited by 44
Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer’s Disease
Martín-Maestro, P., Gargini, R., García, E., Simón, D., Ávila, J., & García‐Escudero, V. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190086 · Cited by 44
The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection
Mnatsakanyan, N., & Jonas, E. A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113400 · Cited by 44
Marzia Perluigi, A., Tramutola, A., Pagnotta, S. E., Barone, E., & Butterfield, D. A. (2020) · Antioxidants · doi:10.3390/antiox9090779 · Cited by 44
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147722 · Cited by 44
Therapeutic options in Alzheimer’s disease
Moreira, P. I., Zhu, X., Nunomura, A., Smith, M. A., & Perry, G. L. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.6.897 · Cited by 44
Self-citationKurata, T., Miyazaki, K., Morimoto, N., Kawai, H., Ohta, Y., Ikeda, Y., & Abe, K. (2013) · Neurological Research · doi:10.1179/1743132812y.0000000127 · Cited by 44
Li, W., Gao, X., Wang, X., Guo, H., & Zhang, B.-L. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.12.017 · Cited by 44
Study of plasma antioxidant status in Alzheimer's disease
Pulido, R., Jiménez‐Escrig, A., Orensanz, L., Saura-Calixto, F. D., & Jiménez‐Escrig, A. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01000.x · Cited by 44
Metadata
- Authors
- Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., & Smith, M. A.
- Affiliations
- Asahikawa Medical University (JP)
- Case Western Reserve University (US)
- Takeda (Japan) (JP)
- Sensei Biotherapeutics (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Nunomura, Akihiko
- ORCID
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08
- Volume
- 60
- Issue
- 8
- Pages
- 759-767
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1542215809
- Cited by
- 1,885
- References
- 59
- Citations by year
- 2026: 46 · 2025: 31 · 2024: 52 · 2023: 61 · 2022: 80 · 2021: 98 · 2020: 86 · 2019: 82 · 2018: 69 · 2017: 73 · 2016: 70 · 2015: 83 · 2014: 86 · 2013: 86 · 2012: 104
- FWCI
- 33.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Asahikawa Medical University Collection and Research (Asahikawa Medical University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag009287-08, AG09287)
- Japan Society for the Promotion of Science (12670918)
- National Institute on Aging (AG-14249, R01AG014249, AG 09287)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, oxidative damage, 8-hydroxyguanosine, nitrotyrosine, amyloid plaques, neurofibrillary tangles, APOE ε4, disease progression, neurodegeneration, reactive oxygen species, RNA oxidation
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Guanosine, Heterozygote, Humans, Male, Middle Aged, Neurons, Tyrosine, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
